135 related articles for article (PubMed ID: 1269156)
1. A critical examination of the value of combined determinations of lecithin:cholesterol acyltransferase and lipoprotein-X in the differential diagnosis of liver disease.
Miller JP; Johnson K
Clin Chim Acta; 1976 May; 69(1):81-4. PubMed ID: 1269156
[TBL] [Abstract][Full Text] [Related]
2. Plasma lecithin:cholesterol acyltransferase activity and the lipoprotein abnormalities of liver disease.
Harry DS; Day RC; Owen JS; Agorastos J; Foo AY; McIntyre N
Scand J Clin Lab Invest Suppl; 1978; 150():223-7. PubMed ID: 746353
[No Abstract] [Full Text] [Related]
3. Lecithin--cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice.
Agorastos J; Fox C; Harry DS; McIntyre N
Clin Sci Mol Med; 1978 Apr; 54(4):369-79. PubMed ID: 205385
[TBL] [Abstract][Full Text] [Related]
4. Effect of heparin on lecithin: cholesterol acyltransferase and lipids in cholestasis.
Rubiés-Prat J; Ras MR; Frisón JC; Miquel C; Masdeu S; Bacardi R
Digestion; 1976; 14(3):250-5. PubMed ID: 955331
[TBL] [Abstract][Full Text] [Related]
5. Lecithin: cholesterol acyl-transferase and lipoprotein-X in liver disease.
Ritland S; Blomhoff JP; Gjone E
Clin Chim Acta; 1973 Dec; 49(2):251-9. PubMed ID: 4772663
[No Abstract] [Full Text] [Related]
6. Lipoprotein-X: a substrate for lecithin: cholesterol acyltransferase.
Patsch JR; Soutar AK; Morrisett JD; Gotto AM; Smith LC
Eur J Clin Invest; 1977 Jun; 7(3):213-7. PubMed ID: 196860
[TBL] [Abstract][Full Text] [Related]
7. Lecithin: cholesterol acyltransferase levels in plasma of patients with hepatobiliary disease.
Palacios Beristáin O; Vázquez I; Segovia Balmes E
Arch Invest Med (Mex); 1984; 15(2):155-62. PubMed ID: 6487005
[No Abstract] [Full Text] [Related]
8. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
Ritland S
Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipids and lipoproteins in liver disease.
McIntyre N
Gut; 1978 Jun; 19(6):526-30. PubMed ID: 355066
[TBL] [Abstract][Full Text] [Related]
10. Lecithin:cholesterol acyltransferase in human liver disease.
Simon JB
Scand J Clin Lab Invest Suppl; 1974; 137():107-13. PubMed ID: 4845397
[No Abstract] [Full Text] [Related]
11. The influence of LP-X and other lipoproteins associated with hepatic dysfunction on the activity of lecithin:cholesterol acyltransferase.
Magnani HN
Biochim Biophys Acta; 1976 Dec; 450(3):390-401. PubMed ID: 188452
[TBL] [Abstract][Full Text] [Related]
12. Effect of portacaval shunt on rat serum lipids, lecithin cholesterol acyltransferase, and lipoproteins.
David JS; Reichle RM; Reichle FA
Surg Forum; 1976; 27(62):371-3. PubMed ID: 1019909
[No Abstract] [Full Text] [Related]
13. Correlation between serum lecithin-cholesterol-acyltransferase activity and erythrocyte lipid content during experimental liver damage.
von Lehmann B; Grajewski O; Oberdisse E
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jul; 298(3):211-6. PubMed ID: 895895
[No Abstract] [Full Text] [Related]
14. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
Palynyczko Z; Milewski B
Mater Med Pol; 1975; 7(4):327-33. PubMed ID: 175222
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein and lecithin: cholesterol acyltransferase changes in galactosamine-induced rat liver injury.
Sabesin SM; Kuiken LB; Ragland JB
Science; 1975 Dec; 190(4221):1302-4. PubMed ID: 812181
[TBL] [Abstract][Full Text] [Related]
16. On the interpretation and potential diagnostic value of the measurements related to lecithin:cholesterol acyltransferase activity.
Lacko AG
Clin Biochem; 1976 Aug; 9(4):212-5. PubMed ID: 954185
[TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase.
Subbaiah PV; Albers JJ; Chen CH; Bagdade JD
J Biol Chem; 1980 Oct; 255(19):9275-80. PubMed ID: 7410425
[TBL] [Abstract][Full Text] [Related]
18. [Lecithin activity: serum cholesterol acyltransferase in hepatic diseases].
Frisón JC; Ras MR; Rubies-Prat J; Masdeu S; Schwartz S; Bacardi R
Rev Clin Esp; 1978 Apr; 149(1):23-6. PubMed ID: 674749
[No Abstract] [Full Text] [Related]
19. Does lipoprotein-X (LP-X) act as a substrate for the lecithin: cholesterol acyltransferase (LCAT)?
Wengeler H; Seidel D
Clin Chim Acta; 1973 May; 45(4):429-32. PubMed ID: 4730213
[No Abstract] [Full Text] [Related]
20. A comparison of heat-inactivated plasma and artificial substrates for lecithin:cholesterol acyltransferase assay in human plasma.
Cheung SW; Christian JC
Clin Chim Acta; 1976 Jun; 69(2):299-304. PubMed ID: 1277560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
